From July 1, 2022 to September 30, 2022, the company has repurchased 844,600 shares, representing 0.14% for CNY 38.16 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.37 CNY | -0.93% | -3.86% | -9.89% |
May. 21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.89% | 4.16B | |
-5.86% | 12.09B | |
-3.26% | 8.21B | |
+5.47% | 5.74B | |
+29.84% | 5.64B | |
-58.02% | 2.88B | |
+11.87% | 2.69B | |
-5.19% | 2.33B | |
+23.98% | 2.17B | |
-4.87% | 1.86B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.